PNC Financial Services Group Inc. lowered its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 5.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 175,474 shares of the medical research company's stock after selling 9,241 shares during the quarter. PNC Financial Services Group Inc. owned about 0.06% of Agilent Technologies worth $20,527,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in A. Pictet Asset Management Holding SA boosted its holdings in shares of Agilent Technologies by 2.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock worth $624,888,000 after purchasing an additional 128,131 shares during the period. Deutsche Bank AG raised its position in Agilent Technologies by 0.9% during the 4th quarter. Deutsche Bank AG now owns 4,436,700 shares of the medical research company's stock valued at $596,026,000 after purchasing an additional 38,348 shares in the last quarter. Northern Trust Corp raised its position in Agilent Technologies by 12.3% during the 4th quarter. Northern Trust Corp now owns 4,192,790 shares of the medical research company's stock valued at $563,259,000 after purchasing an additional 457,713 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Agilent Technologies by 9.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,231,981 shares of the medical research company's stock valued at $434,184,000 after purchasing an additional 283,445 shares in the last quarter. Finally, Impax Asset Management Group plc raised its position in shares of Agilent Technologies by 3.6% in the 1st quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company's stock worth $342,961,000 after acquiring an additional 102,365 shares in the last quarter.
Insider Buying and Selling at Agilent Technologies
In related news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Wall Street Analyst Weigh In
Several analysts recently commented on A shares. UBS Group dropped their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday, May 29th. Barclays raised their target price on Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a report on Tuesday, June 24th. Evercore ISI raised their target price on Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, Jefferies Financial Group lowered their price target on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $139.77.
Check Out Our Latest Report on Agilent Technologies
Agilent Technologies Stock Performance
NYSE A traded up $0.10 on Tuesday, hitting $114.94. 1,271,032 shares of the company's stock were exchanged, compared to its average volume of 1,869,476. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60. The firm's 50-day moving average price is $117.21 and its two-hundred day moving average price is $120.24. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The firm has a market cap of $32.65 billion, a price-to-earnings ratio of 28.38, a P/E/G ratio of 3.48 and a beta of 1.22.
Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The company's revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.
Agilent Technologies Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st were paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Tuesday, July 1st. Agilent Technologies's dividend payout ratio is currently 24.44%.
Agilent Technologies Company Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
